Cargando…
Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study
To date, no therapeutic strategy has been shown to be effective in reducing the risk of polycythemia vera (PV) transforming into myelofibrosis or leukemia, and the main goal of current treatment is to prevent thrombotic events. Recent studies have shown that higher levels of inflammation are associa...
Autores principales: | Lai, Hurong, Tu, Yansong, Zhang, Shan, Liao, Caifeng, Tu, Huaijun, Li, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640535/ https://www.ncbi.nlm.nih.gov/pubmed/37907800 http://dx.doi.org/10.1007/s00277-023-05518-6 |
Ejemplares similares
-
The Predictive Value of Neutrophil-Lymphocyte Ratio in Patients with Polycythemia Vera at the Time of Initial Diagnosis for Thrombotic Events
por: Wang, Xuekun, et al.
Publicado: (2022) -
Pulmonary vein thrombosis in a patient with polycythemia vera
por: Bhardwaj, Bhaskar, et al.
Publicado: (2016) -
European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera
por: Tremblay, Douglas, et al.
Publicado: (2022) -
RBC distribution width predicts thrombosis risk in polycythemia vera
por: Liu, Dan, et al.
Publicado: (2021) -
Phenotypical differences and thrombosis rates in secondary erythrocytosis versus polycythemia vera
por: Nguyen, Eliane, et al.
Publicado: (2021)